drugset / Trial / NCT05635110
Evaluation of the Effects of Omeprazole and Rifampin on the Pharmacokinetics of VX-548 in Healthy Participants
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to evaluate the pharmacokinetics and safety of VX-548 and its metabolite in the absence and presence of omeprazole or rifampin, in healthy participants.
Timeline
- Start
- 2022-12-15
- Primary completion
- 2023-06-08
- Completion
- 2023-06-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omeprazole | Other / unclassified | — | Oral |
| Subject | Rifampin | Small molecule | — | Oral |
| Subject | Suzetrigine | Small molecule | — | Oral |
Indications
No indication recorded.